Forty-three patients with MM (n=27) or NSCLC (n=16) were enroled between 2007 and 2009 (Table 1).
In all, 41 eligible patients with histological verified oesophageal carcinoma were enroled between December 2006 and July 2009.
Eligible patients were enroled between July, 2003 and April, 2005, and randomly assigned to 25 mg of intravenous (i.v).v
A random sample of 32 patients was taken from patients who had enroled between September and November 2007.
Eighty-two patients were enroled between July 2005 and July 2008 at The Netherlands Cancer Institute, Amsterdam, The Netherlands, and at the Beatson West of Scotland Cancer Centre, Glasgow, UK.
In the phase II study, all 36 patients enroled between February 2005 and February 2008 met all eligibility requirements and received at least one course of treatment.
In all 23 patients with a median age of 56 years (range 39 66) were enroled between August 2005 and August 2006; the demographics are described on Table 1.
Sixty-five Indian women enroled between February 2003 and March 2004 at the All India Institute of Medical Sciences in New Delhi, the Christian Medical College and Hospital in Vellore, and the Hirabai Cowasji Jehangir Medical Research Institute, Jehangir Hospital, in Pune.
A total of 47 patients were enroled between December 2004 and January 2010, with 27 and 20 patients treated with the 1- and 3-h schedules of PM00104, respectively (Table 1).
In the state of New South Wales, preschools provide centre-based care for 6 8 h/day and enrol children between 3 and 6 years.
